NIHR Maudsley BRC Blog

Our latest news & events

Making referrals to the AVATAR2 trial: An interview with Dr Helen Harding

The AVATAR2 trial is a multi-centre study of therapy aiming to help people who hear distressing voices by enabling them to build an avatar to represent the owner of the voice. Referrers play a pivotal role by recommending participants take part in the trial. Here Clinical Psychologist, Dr Helen Harding, talks about the referral process and how she sees the research benefitting patients in the short and long term. Dr Harding is a Clinical Psychologist in Lambeth Community Services.

By NIHR Maudsley BRC at 20 May 2022

Professor Peter Goadsby elected to the Fellowship of the Royal Society

Professor Peter Goadsby, Theme lead for Pain at the National Institute for Health and Care Research (NIHR) Maudsley Biomedical Research Centre, has been elected to the Fellowship of the Royal Society, a Fellowship of many of the world’s most eminent scientists and the oldest academy in continuous existence.

By NIHR Maudsley BRC at 10 May 2022

NIHR Maudsley BRC researchers lead first study of psilocybin in adults with autism

Researchers from King’s College London and South London and Maudsley NHS Foundation Trust will be leading the first ever study of psilocybin in adults with autism spectrum disorder (ASD). 

By NIHR Maudsley BRC at 9 May 2022

Autism, ADHD and school absence are risk factors for self-harm, according to new study

Research led by King’s College London and South London and Maudsley NHS Foundation Trust has analysed factors associated with self-harm in over 111,000 adolescents aged 11-17 years old.

By NIHR Maudsley BRC at 29 Apr 2022

Multi-variant vaccine study opens at King's CRF

A new vaccine study which will assess the safety and efficacy of a vaccine will will target multiple variants of the COVID-19-causing Sars-CoV-2 virus - including the current dominant variant Omicron.

By NIHR Wellcome King's Clinical Research Facility at 13 Apr 2022